Technical Description
The technology describes cocrystals of dimethyl fumarate (DMF) prepared with acid-based coformers to treat multiple sclerosis and psoriasis, leveraging its immune-modulating and anti inflammatory properties.
Problems Addressed
- Prone to Sublimation
- Cytotoxic Effect
- Oxidization Damage
- Complex Formulation
Tech Features
- Enhanced Thermal Stability
- No Cytotoxic Effect
- Anti-Inflammatory Activity
- High Anti-Oxidant Activity
- Improved Physiochemical Properties
- Thermal Stability Evaluation
Target Audience
- Pharmaceutical Industry
- Agriculture Sector
- Polymer Industry
- Medical & Healthcare Sector
Tech ID: P27-1662 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
